Intravenous infusion, tocilizumab-anoh, for hospitalized adult patients with covid-19 who are receiving systemic corticosteroids and require supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation (ecmo) only, includes infusion and post administration monitoring, second dose

Code type

HCPCS Level II

Coverage

Carrier judgment

BETOS category

O1G

Pricing indicator

54

Effective date

20250124